Nancy Ellen Davidson MD
Breast Cancer, Hematologic Oncology
Professor, Medicine, University of Pittsburgh School of Medicine
Join to View Full Profile
200 Lothrop StPittsburgh, PA 15213
Phone+1 412-623-3205
Fax+1 412-623-3210
Dr. Davidson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1986- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1985
Johns Hopkins UniversityResidency, Internal Medicine, 1980 - 1982
University of Pennsylvania Health SystemInternship, Internal Medicine, 1979 - 1980
Pennsylvania Hospital of the University of Pennsylvania Health SystemInternship, Internal Medicine, 1979 - 1980
Wellesley CollegeBA, 1975 - 1979
Harvard Medical SchoolClass of 1979
Certifications & Licensure
MD State Medical License 1982 - 2026
PA State Medical License 1979 - 2026
WA State Medical License 2017 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow, American College of Physicians
- The Johns Hopkins Women's Medical Alumnae Association Hall of Fame 2015
- Thomas Reutgers Highly Cited Researchers 2014
- Join now to see all
Clinical Trials
- Combination Chemotherapy in Treating Patients With Breast Cancer Start of enrollment: 1997 Sep 01
- Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer Start of enrollment: 2000 May 19
Publications & Presentations
PubMed
- Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.Karin Ribi, Bernard F Cole, Gini F Fleming, Barbara A Walley, Prudence A Francis
Cancer. 2025-10-01 - RecOVARY? Using anti-Müllerian hormone to predict ovarian function after anti-HER2 therapy for early breast cancer.Lynn K Symonds, Nancy E Davidson
Journal of the National Cancer Institute. 2025-09-26 - Drug screening in 3D microtumors reveals DDR1/2-MAPK12-GLI1 as a vulnerability in cancer-associated fibroblasts.Nao Nishida-Aoki, Songli Zhu, Marina Chan, Yuqi Kang, Maihi Fujita
Cell Reports. Medicine. 2025-09-19
Press Mentions
With Respiratory Infections Rampant, Experts Urge Masking and VaccinationMarch 13th, 2025- Study Identifies Molecular Differences Between Primary Breast Cancer and Its MetastasesJanuary 9th, 2023
- Fred Hutch/UW Cancer Consortium Breast Cancer Researchers Receive GrantsNovember 17th, 2022
- Join now to see all
Grant Support
- Senior LeadershipNational Cancer Institute2010–2011
- Planning And EvaluationNational Cancer Institute2010–2011
- DevelopmentalNational Cancer Institute2010–2011
- Cancer Center Support GrantNational Cancer Institute2010–2011
- Exploiting Epigenetic Alterations In BCNational Cancer Institute2006–2010
- Career Development ProgramNational Cancer Institute2006–2010
- Administration CoreNational Cancer Institute2006–2010
- Cancer Center SupportNational Cancer Institute2008–2009
- Spore In Breast CancerNational Cancer Institute2000–2008
- Use Of Demethylating And Histone Deacetylating AgentsNational Cancer Institute2000–2002
- Core--CommunicationNational Cancer Institute2000–2002
- DNA Methylation As A Determinant Of Breast CancerNational Cancer Institute1998–2002
- New Therapeutic Approaches For Breast CancerNational Cancer Institute1995–1998
- Development Of Breast Cancer ProgramNational Cancer Institute1994–1997
- Development Of Breast Cancer ProgramNational Cancer Institute1994
- Programmed Cell Death In Human Breast Cancer CellsNational Cancer Institute1992–1993
- Epidermal Growth Factor Receptor In Human Breast CancerNational Cancer Institute1989–1993
Professional Memberships
- Member
- Fellow
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
